Hailing Lu Selected Research

VTX-2337

1/2018	TLR8 ligation induces apoptosis of monocytic myeloid-derived suppressor cells.
1/2016	Coordinated Activation of Toll-Like Receptor8 (TLR8) and NLRP3 by the TLR8 Agonist, VTX-2337, Ignites Tumoricidal Natural Killer Cell Activity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hailing Lu Research Topics

Disease

39	Neoplasms (Cancer) 01/2022 - 07/2006
17	Breast Neoplasms (Breast Cancer) 12/2019 - 07/2006
8	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020 - 11/2013
8	Neoplasm Metastasis (Metastasis) 01/2020 - 11/2011
5	Adenocarcinoma of Lung 01/2020 - 07/2018
5	Lung Neoplasms (Lung Cancer) 01/2020 - 11/2013
2	Synovial Sarcoma (Synovioma) 01/2022 - 10/2017
2	Lymphoma (Lymphomas) 01/2020 - 05/2003
2	Inflammation (Inflammations) 01/2020 - 05/2010
2	Testicular Neoplasms (Testicular Cancer) 10/2019 - 10/2017
2	Pathologic Processes 01/2018 - 12/2015
2	Carcinogenesis 09/2014 - 01/2013
1	Sarcoma (Soft Tissue Sarcoma) 01/2022
1	Myxoid Liposarcoma 01/2022
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2022
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2020
1	Triple Negative Breast Neoplasms 12/2019
1	Pathologic Complete Response 01/2019
1	Necrosis 01/2018
1	Squamous Cell Carcinoma of Head and Neck 01/2016
1	Lymphatic Metastasis 12/2013

Drug/Important Bio-Agent (IBA)

14	Proteins (Proteins, Gene)FDA Link 01/2020 - 03/2002
9	AntigensIBA 12/2019 - 10/2006
6	ErbB Receptors (EGF Receptor)IBA 01/2020 - 11/2013
5	VaccinesIBA 11/2020 - 08/2006
5	Biomarkers (Surrogate Marker)IBA 07/2018 - 02/2007
5	AntibodiesIBA 05/2014 - 12/2004
4	Tyrosine Kinase InhibitorsIBA 01/2020 - 01/2018
4	AutoantibodiesIBA 05/2014 - 04/2008
3	Gefitinib (Iressa)FDA Link 01/2020 - 05/2016
3	Biological ProductsIBA 01/2018 - 01/2011
3	Cisplatin (Platino)FDA LinkGeneric 01/2018 - 12/2015
3	polysaccharide-KIBA 08/2013 - 01/2011
3	Trastuzumab (Herceptin)FDA Link 11/2011 - 10/2009
2	Toll-Like Receptor 4IBA 01/2022 - 01/2020
2	Oncogene Proteins (Oncogene Protein)IBA 01/2020 - 01/2013
2	Ubiquitin-Specific ProteasesIBA 01/2020 - 10/2018
2	Small Interfering RNA (siRNA)IBA 01/2020 - 01/2020
2	MicroRNAs (MicroRNA)IBA 11/2018 - 12/2015
2	Cadherins (E-Cadherin)IBA 07/2018 - 12/2013
2	VTX-2337IBA 01/2018 - 01/2016
2	Imiquimod (Aldara)FDA LinkGeneric 07/2017 - 05/2010
2	Toll-Like Receptors (Toll-Like Receptor)IBA 07/2017 - 03/2011
2	Estrogen ReceptorsIBA 09/2014 - 10/2006
2	Toll-Like Receptor AgonistsIBA 01/2014 - 05/2010
2	Polysaccharides (Glycans)IBA 04/2012 - 01/2011
2	Neoplasm Antigens (Tumor Antigens)IBA 04/2008 - 10/2006
1	atezolizumabIBA 01/2022
1	B7-H1 AntigenIBA 01/2022
1	pembrolizumabIBA 01/2022
1	Recombinant ProteinsIBA 11/2020
1	EmulsionsIBA 01/2020
1	glucopyranosyl lipid-AIBA 01/2020
1	Complementary DNA (cDNA)IBA 12/2019
1	Pharmaceutical PreparationsIBA 11/2018
1	Deubiquitinating EnzymesIBA 10/2018
1	ELAV-Like Protein 2IBA 07/2018
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2018
1	130-nm albumin-bound paclitaxelIBA 07/2017
1	Albumin-Bound Paclitaxel FDA Link 07/2017
1	sphingosine kinaseIBA 05/2016
1	Cetuximab (Erbitux)FDA Link 01/2016
1	nedaplatinIBA 01/2016
1	Monoclonal AntibodiesIBA 01/2016
1	Toll-Like Receptor 8IBA 01/2016
1	Insulin Receptor Substrate ProteinsIBA 10/2014
1	Forkhead Box Protein M1IBA 09/2014
1	Hormones (Hormone)IBA 09/2014
1	Tamoxifen FDA LinkGeneric 09/2014
1	Forkhead Transcription Factors (Forkhead Box Proteins)IBA 09/2014
1	Mitogen-Activated Protein Kinase 1 (p42 MAP Kinase)IBA 09/2014
1	ChromatinIBA 09/2014
1	Immunoglobulin M (IgM)IBA 05/2014
1	Immunoglobulin G (IgG)IBA 05/2014
1	Cell Adhesion MoleculesIBA 12/2013
1	CateninsIBA 12/2013
1	OsteopontinIBA 12/2013
1	Caveolin 1IBA 11/2013
1	ParaffinIBA 11/2013
1	Aromatase InhibitorsIBA 08/2013
1	Diphosphonates (Bisphosphonates)IBA 08/2013
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 08/2013
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 08/2013
1	Transferrin (beta 2 Transferrin)IBA 01/2013
1	artemisinin (artemisinine)IBA 01/2013
1	SurvivinIBA 01/2013
1	Epidermal Growth Factor (EGF)IBA 01/2013
1	beta CateninIBA 01/2013
1	Cyclin D1IBA 01/2013
1	Prednisolone (Predate)FDA LinkGeneric 08/2012
1	Cyclin B1IBA 08/2012
1	Carcinoembryonic AntigenIBA 08/2012
1	Messenger RNA (mRNA)IBA 04/2012

Therapy/Procedure

11	Therapeutics 01/2022 - 07/2006
7	Drug Therapy (Chemotherapy) 11/2018 - 11/2011
6	Immunotherapy 01/2020 - 07/2006
2	Injections 01/2022 - 01/2020
1	Time-to-Treatment 01/2016
1	Chemoprevention 08/2013
1	Castration 04/2012